Would Transdermal Low Dose Naltrexone (LDN) Be Good at Controlling Cutaneous Mastocytosis?

Would Transdermal Low Dose Naltrexone (LDN) Be Good at Controlling Cutaneous Mastocytosis?

Answered by Nat Jones, R.Ph. FAPC

For information on LDN, go to https://linktr.ee/ldnrt

Our webinar can be purchased https://[a]www.ldnrtevents.com%2Fcollections%2Fwebinars-and-training-courses[/a] and we have a list of LDN Q&As on our website https://ldnresearchtrust.org/questions-and-answers

Checkout our LDN Webinars https://[a]www.ldnrtevents.com%2Fcollections%2Fwebinars-and-training-courses[/a]Check out www.ldnrtevents.com for LDN Webinars, The LDN Book 3, eBooks, Medical Membership etc

Please visit our website https://www.ldnresearchtrust.org which is packed with information on Low Dose Naltrexone (LDN) for Autoimmune Conditions, Cancers, Chronic Pain, Women's Health, Children's Health etc, plus we have a very active FB Closed Group https://www.facebook.com/groups/LDNRT/